Delayed
Other stock markets
|
|
5-day change | 1st Jan Change | |
501.59 USD | -0.80% | -1.41% | -8.92% |
Sep. 21 | Thermo Fisher Scientific Inc. Appoints Jennifer ?Jenny? Johnson to the Audit Committee | CI |
Sep. 21 | Southern Company Subsidiary Acquires Millers Branch Solar Facility in Texas | MT |
Business Summary
- laboratory equipments (70%). Moreover, the group proposes chemical products (reagents, solvent, salts, etc.), consumable products (tubes, funnels, vials, etc.), as well as conditioning, warehousing, storage, etc.;
- diagnostics equipment and products (15.3%);
- scientific analysis equipments (14.7%): analyzer (of water, gas, grounds, etc.), mass spectrometers, molecular spectroscopes, microscopes, manometers, samplers, microbiology equipments, reactive agents, etc.
Net sales break down by source of income into products sales (78.5%) and services (21.5%).
Net sales break down geographically as follows: North America (53%), Europe (25.7%), Asia-Pacific (18.1%) and others (3.2%).
Number of employees : 130,000
Sales per Business
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Laboratory Products and Biopharma Services
50.1
%
| 14,862 | 37.9 % | 22,511 | 50.1 % | +51.47% |
Life Sciences Solutions
30.1
%
| 15,631 | 39.9 % | 13,532 | 30.1 % | -13.43% |
Analytical Instruments
14.7
%
| 6,069 | 15.5 % | 6,624 | 14.7 % | +9.14% |
Specialty Diagnostics
10.6
%
| 5,659 | 14.4 % | 4,763 | 10.6 % | -15.83% |
Eliminations
-5.6
%
| -3,010 | -7.7 % | -2,515 | -5.6 % | -16.45% |
Sales per region
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
United States
53.0
%
| 18,907 | 48.2 % | 23,820 | 53.0 % | +25.99% |
Europe
24.0
%
| 11,134 | 28.4 % | 10,762 | 24.0 % | -3.34% |
Asia-Pacific
9.6
%
| 3,774 | 9.6 % | 4,322 | 9.6 % | +14.52% |
China
8.4
%
| 3,444 | 8.8 % | 3,793 | 8.4 % | +10.13% |
Other Regions
3.2
%
| 1,200 | 3.1 % | 1,444 | 3.2 % | +20.33% |
North America
1.7
%
| 752 | 1.9 % | 774 | 1.7 % | +2.93% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 54 | 2009 |
Director of Finance/CFO | 56 | 2015 | |
Michel Lagarde
COO | Chief Operating Officer | 48 | 2021 |
David Johnston
CTO | Chief Tech/Sci/R&D Officer | 54 | 2021 |
Ryan Snyder
CTO | Chief Tech/Sci/R&D Officer | - | 2018 |
Karen Nelson
CTO | Chief Tech/Sci/R&D Officer | - | - |
Alan Sachs
CTO | Chief Tech/Sci/R&D Officer | - | 2015 |
Rafael Tejada
IRC | Investor Relations Contact | - | 2015 |
Garret Hampton
PRN | Corporate Officer/Principal | 57 | - |
John Brian Sabo
PRN | Corporate Officer/Principal | 53 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Marc Casper
CHM | Chairman | 54 | 2020 |
Scott Sperling
BRD | Director/Board Member | 65 | 2006 |
Nelson Chai
BRD | Director/Board Member | 57 | 2010 |
R. Keith
BRD | Director/Board Member | - | 2020 |
Tyler Jacks
BRD | Director/Board Member | 62 | 2009 |
C. Harris
BRD | Director/Board Member | 66 | 2012 |
Director/Board Member | 69 | 2016 | |
Dion Weisler
BRD | Director/Board Member | 55 | 2017 |
Ruby Chandy
BRD | Director/Board Member | 61 | 2022 |
James Mullen
BRD | Director/Board Member | 64 | 2018 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 441,398,059 | 385,226,649 ( 87.27 %) | 55,448,286 ( 12.56 %) | 87.27 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
SCIENCE 37 HOLDINGS, INC. 14.84% | 17,379,797 | 14.84% | 4,344,949 $ |
AIFORIA TECHNOLOGIES OYJ 7.55% | 1,959,200 | 7.55% | 8,973,489 $ |
Company contact information
Thermo Fisher Scientific, Inc.
168 Third Avenue
02451, Waltham
+1 781 622 1000
http://www.thermofisher.com
Group companies
Name | Category and Sector | Since |
---|---|---|
Health Technology - Medical Specialties
| 2018 | |
Thermo Fisher Scientific India Pvt Ltd.
|
Health Technology - Pharmaceuticals: Major
| 2000 |
Fisher Scientific Luxembourg SARL
|
-
| 2018 |
Thermo Fisher Scientific (Ecublens) SARL
|
-
| 2020 |
Fisher Scientific (PN1) UK Ltd.
|
-
| 2021 |
FEI Electron Optics BV
|
-
| 2017 |
Thermo Fisher Scientific (IVGN) BV
|
Finance - Financial Conglomerates
| 2017 |
Phadia International Holdings CV
|
-
| 2018 |
Thermo Fisher Scientific (Finance I) BV
|
Finance - Finance/Rental/Leasing
| 2017 |
Sector
Sales per Business
Sales per region
Trading Rating :
Investor Rating :
ESG Refinitiv :
B
Sell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
501.59USD
Average target price
624.57USD
Spread / Average Target
+24.52%
EPS Revisions
1st Jan change | Capi. (M$) | |
---|---|---|
-8.92% | 198 B $ | |
-6.85% | 186 B $ | |
+9.57% | 103 B $ | |
+14.18% | 78 775 M $ | |
+1.26% | 56 011 M $ | |
-13.80% | 45 707 M $ | |
-5.68% | 42 226 M $ | |
-26.01% | 32 752 M $ | |
+13.41% | 30 238 M $ | |
-36.25% | 20 802 M $ |